Michael’s wife, Teresa, added, “If we can save a life, we will tell anyone our story.” It’s a story that could have ended when Michael was 14 years old, when he had his first aneurysm. Michael had ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which has no cure to date. This disease ...

Marfan syndrome affects the body’s connective tissues, which hold cells, organs and tissues together. They are also important in the the body’s growth and development. Some characteristics are evident ...

A study reveals that inflammation associated with Marfan syndrome increases vulnerability to neurological diseases and complications following strokes, as demonstrated in animal models. A study by the ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which has no cure to date. This disease ...

One of the priority objectives of research into rare diseases is to develop new treatments, and orphan medicines — which target conditions affecting no more than 5 in 10,000 people in the EU — provide ...

I was born with Marfan syndrome, a rare genetic condition that affects the body’s connective tissues, which I inherited from my father. The disease has weakened my eyesight due to dislocated lenses ...